Foot Diseases: Clinical Trials

2 trials for Foot Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Withdrawn 2
Phase 21Withdrawn 1

Follow Foot Diseases: new trials by email Literature Review of Foot Diseases trials Research Report on Foot Diseases

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis
Dapaconazole, Ketoconazole - Tinea Pedis
Phase 3WithdrawnBiolab Sanus Farmaceutica2016-06-012017-02-01
Comparing Steroid Injections and Platelet Rich Plasma Injections in the Treatment of Plantar Fasciitis
Corticosteroid injection (Bupivacaine and Depo Medrol), Platelet rich plasma injection - Plantar Fasciitis
Phase 2 / Phase 3WithdrawnKing Hamad University Hospital, Bahrain2013-06-012019-08-16

Narrower conditions

Fasciitis, Plantar (1)  ·  Tinea Pedis (1)

Broader conditions

Bacterial Infections and Mycoses (1)  ·  Dermatomycoses (1)  ·  Fasciitis (1)  ·  Foot Dermatoses (1)  ·  Infections (1)  ·  Musculoskeletal Diseases (1)  ·  Mycoses (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pruritus (1)  ·  Signs and Symptoms (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Infectious (1)  ·  Skin Manifestations (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

1-(2-(2,4-dichlorophenyl)-2-(4-(trifluoromethyl)benzyloxy)ethyl)-1H-imidazole (1)  ·  Adrenal Cortex Hormones (1)  ·  Bupivacaine (1)  ·  Ketoconazole (1)  ·  Methylprednisolone Acetate (1)

Sponsors

Biolab Sanus Farmaceutica (1)  ·  King Hamad University Hospital, Bahrain (1)

Countries

Bahrain (1)  ·  Brazil (1)

Top investigators

Aamina M Khan (1)  ·  Ahsan J Butt (1)  ·  Gilberto De Nucci, PhD (1)